Design Therapeutics, Inc.盘中异动早盘大幅拉升5.24%报4.17美元

市场透视2025-04-23

北京时间2025年04月23日21时34分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.17美元/股，成交量4376股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-49.59百万美元，每股收益-0.88美元，毛利-596000.00美元，市盈率-4.70倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529750680?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-23 21:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529750680","market":"us","top_or_hot":-1,"title":"Design Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%报4.17美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月23日21时34分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.17美元/股，成交量4376股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-49.59百万美元，每股收益-0.88美元，毛利-596000.00美元，市盈率-4.70倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213412a463fa59&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Design Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%报4.17美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDesign Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%报4.17美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-23 21:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213412a463fa59&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月23日21时34分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.17美元/股，成交量4376股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-49.59百万美元，每股收益-0.88美元，毛利-596000.00美元，市盈率-4.70倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213412a463fa59&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213412a463fa59&s=b","article_id":"2529750680","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213412a463fa59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529750680","pubTimestamp":1745415252,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月23日21时34分，Design Therapeutics, Inc.股票出现异动，股价快速拉升5.24%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BK4539":"次新股","BK4505":"高瓴资本持仓","DSGN":"Design Therapeutics, Inc.","BK4139":"生物科技","BK4007":"制药"},"translate_title":"Design Therapeutics, Inc. rose 5.24% to $4.17 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DSGN":1,"LENZ":1},"content_text":"北京时间2025年04月23日21时34分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.17美元/股，成交量4376股，换手率0.01%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-49.59百万美元，每股收益-0.88美元，毛利-596000.00美元，市盈率-4.70倍。机构评级方面，在所有3家参与评级的机构中，33%的券商给予买入建议，67%的券商给予持有建议，无券商给予卖出建议。Design Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Rezolute, Inc.涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为3204.17%、18.95%、10.06%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Seres Therapeutics, Inc.，振幅分别为41.18%、29.61%、16.91%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC™ 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。公司的产品候选物针对弗里德赖希共济失调症（FA），第二个产品候选物针对 Fuchs 内皮角膜营养不良症（FECD），并且还在推进其 GeneTAC™ 项目以解决其他严重的核苷酸重复驱动的单基因疾病。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529750680","isCrawlerRequest":true}

Design Therapeutics, Inc.盘中异动 早盘大幅拉升5.24%报4.17美元

精彩评论

Design Therapeutics, Inc.盘中异动早盘大幅拉升5.24%报4.17美元